Neogen (NEOG) Net Margin Growth (3y) (2013 - 2026)
Neogen (NEOG) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 300.00 |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | -433.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -433.00 |
| Feb 28, 2026 | -1,180.00 |
| Nov 30, 2025 | 1,110.00 |
| Aug 31, 2025 | 1,344.00 |
| May 31, 2025 | -29,908.00 |
| Feb 28, 2025 | -918.00 |
| Nov 30, 2024 | -20,560.00 |
| Aug 31, 2024 | -1,912.00 |
| May 31, 2024 | -1,354.00 |
| Feb 29, 2024 | -1,235.00 |
| Nov 30, 2023 | -1,533.00 |
| Aug 31, 2023 | -1,385.00 |
| May 31, 2023 | -1,235.00 |
| Feb 28, 2023 | -846.00 |
| Nov 30, 2022 | -3,329.00 |
| Aug 31, 2022 | -1,051.00 |
| May 31, 2022 | -426.00 |
| Feb 28, 2022 | -914.00 |
| Nov 30, 2021 | -669.00 |
| Aug 31, 2021 | -198.00 |